Wockhardt

Wockhardt Ltd.
Company typePublic
NSEWOCKPHARMA
BSE532300
IndustryPharmaceuticals
Health care
Founded1960s
FounderHabil Khorakiwala
HeadquartersWockhardt Towers, Bandra Kurla Complex, Mumbai, Maharashtra, India
Area served
Worldwide
Key people
Habil Khorakiwala (Chairman)
Murtaza Khorakiwala (Managing director)
Huzaifa Khorakiwala (Executive Director)
ProductsFormulations
Biopharmaceuticals
Vaccines
RevenueDecrease 2,693 crore (US$320 million) (FY23)[1]
Negative increase −621 crore (US$−74 million) (FY23)[1]
Number of employees
3,000 (2023)
SubsidiariesMorton Grove Pharma[2]
Websitewww.wockhardt.com
Footnotes / references
[3]

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, India. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs).[4] The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France.[5][6]

  1. ^ a b "Wockhardt posts net loss of Rs 237 crore in Q4 FY 23". The Economic Times. 27 May 2023. Retrieved 2 March 2024.
  2. ^ "Wockhardt acquires US-based Morton Grove". The Economic Times. 24 October 2007. Retrieved 16 February 2023.
  3. ^ "Audited Financial Results For The Quarter And Year Ended 31.03.2021" (PDF). BSE. Retrieved 27 May 2021.
  4. ^ "Wockhardt – Who we are".
  5. ^ Cite error: The named reference birlaa was invoked but never defined (see the help page).
  6. ^ "Wockhardt set to join billion-dollar club". Business Standard India. Business Standard. 20 March 2013. Retrieved 20 March 2013.